Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

Disease (cancer type)

Lung Cancer

Contact information

  • North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Patient Selection Criteria

The study will collect data primarily from oncology care facilities in Australia, the EU, Switzerland, and the US. Electronic case report forms will be used by study investigators or qualified research staff members to enter data. As part of the routine care, study investigators will evaluate or ask patients about their disease history, treatment history, and any AE experienced at the time of patient enrollment and during the study period. If an SAE is treated outside of the study sites, the information about the SAE, management, and outcomes will be obtained by study investigators or study staff from the healthcare facilities where patients’ SAEs are treated and managed in compliance with country regulations for human research ethics and privacy

Research sponsor

Bristol-Myers Squibb

Reference ID#

BMS CA209-234

State(s)

  • Florida

Linked Physicians

Back
To top